Farklı diyaliz modalitelerinin hasta yakını yaşam kalitesi üzerindeki etkileri
Öz
Anahtar Kelimeler
Kaynakça
- Carney EF. The impact of chronic kidney disease on global health. Nat Rev Nephrol. 2020; 16 (5): 251.
- Saran R, Robinson B, Abbott KC, Agodoa LYC, Bragg-Gresham J, Balkrishnan R, et al. US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2019; 73 (3 Suppl 1): A7-A8.
- Queeley GL, Campbell ES. Comparing Treatment Modalities for End-Stage Renal Disease: A Meta-Analysis. Am Health Drug Benefits. 2018; 11 (3): 118-27.
- Demiral Y, Ergor G, Unal B, Semin S, Akvardar Y, Kivircik B, et al. Normative data and discriminative properties of short form 36 (SF-36) in Turkish urban population. BMC Public Health. 2006; 6: 247.38 Ege Tıp Dergisi / Ege Journal of Medicine
- Pinar R. Reliability and construct validity of the SF-36 in Turkish cancer patients. Qual Life Res. 2005; 14 (1): 259-64.
- Ng JK, Li PK. Chronic kidney disease epidemic: How do we deal with it? Nephrology (Carlton). 2018; 23 Suppl 4: 116-20.
- Trinh E, Chan CT, Perl J. Dialysis modality and survival: Done to death. Semin Dial. 2018; 31 (4): 315-24.
- Tang SCW, Lai KN. Peritoneal dialysis: the ideal bridge from conservative therapy to kidney transplant. J Nephrol. 2020. 2020 Jul 11: 1–6.
Ayrıntılar
Birincil Dil
Türkçe
Konular
Sağlık Kurumları Yönetimi
Bölüm
Araştırma Makalesi
Yazarlar
Cenk Gökalp
*
0000-0003-3909-7973
Türkiye
Yayımlanma Tarihi
31 Mart 2021
Gönderilme Tarihi
15 Eylül 2020
Kabul Tarihi
17 Kasım 2020
Yayımlandığı Sayı
Yıl 2021 Cilt: 60 Sayı: 1